Cargando…

A multimodal marker for cognitive functioning in multiple sclerosis: the role of NfL, GFAP and conventional MRI in predicting cognitive functioning in a prospective clinical cohort

BACKGROUND: Cognitive impairment in people with MS (PwMS) has primarily been investigated using conventional imaging markers or fluid biomarkers of neurodegeneration separately. However, the single use of these markers do only partially explain the large heterogeneity found in PwMS. OBJECTIVE: To in...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dam, Maureen, de Jong, Brigit A., Willemse, Eline A. J., Nauta, Ilse M., Huiskamp, Marijn, Klein, Martin, Moraal, Bastiaan, de Geus-Driessen, Sanne, Geurts, Jeroen J. G., Uitdehaag, Bernard M. J., Teunissen, Charlotte E., Hulst, Hanneke E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344976/ https://www.ncbi.nlm.nih.gov/pubmed/37101095 http://dx.doi.org/10.1007/s00415-023-11676-4

Ejemplares similares

Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy
por: van Ballegoij, Wouter J. C., et al.
Publicado: (2020)

Performance validity in outpatients with multiple sclerosis and cognitive complaints
por: Nauta, IM, et al.
Publicado: (2021)

Minocycline treatment in clinically isolated syndrome and serum NfL, GFAP, and metalloproteinase levels
por: Camara-Lemarroy, Carlos, et al.
Publicado: (2022)

Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis
por: Huiskamp, Marijn, et al.
Publicado: (2021)

A randomized trial predicting response to cognitive rehabilitation in multiple sclerosis: Is there a window of opportunity?
por: Prouskas, Stefanos E, et al.
Publicado: (2022)

Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis
por: Simon, Shira, et al.
Publicado: (2023)

Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19
por: Bark, Lovisa, et al.
Publicado: (2023)

Cognitive functioning in everyday life: The development of a questionnaire on instrumental activities of daily living in multiple sclerosis
por: van Dam, Maureen, et al.
Publicado: (2021)

A more unstable resting-state functional network in cognitively declining multiple sclerosis
por: Broeders, Tommy A. A., et al.
Publicado: (2022)

Emergence delirium and postoperative delirium associated with high plasma NfL and GFAP: an observational study
por: Liu, Xingyang, et al.
Publicado: (2023)

Functional brain network organization measured with magnetoencephalography predicts cognitive decline in multiple sclerosis
por: Nauta, Ilse M, et al.
Publicado: (2020)

Sex Differences in Behavioral Symptoms and the Levels of Circulating GFAP, Tau, and NfL in Patients With Traumatic Brain Injury
por: Sass, Dilorom, et al.
Publicado: (2021)

miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis
por: Scaroni, Federica, et al.
Publicado: (2022)

The clinical value of the patient-reported multiple sclerosis neuropsychological screening questionnaire
por: Nauta, Ilse M, et al.
Publicado: (2018)

Cognitive performance in multiple sclerosis: what is the role of the gamma-aminobutyric acid system?
por: Huiskamp, Marijn, et al.
Publicado: (2023)

Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis
por: Barro, Christian, et al.
Publicado: (2022)

Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
por: Youssef, Priscilla, et al.
Publicado: (2023)

Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): a study protocol for a randomised controlled trial
por: Nauta, Ilse M., et al.
Publicado: (2017)

Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients
por: Halbgebauer, Rebecca, et al.
Publicado: (2022)

Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients
por: Ferrari, Federica, et al.
Publicado: (2023)

A pilot study of the effects of running training on visuospatial memory in MS: A stronger functional embedding of the hippocampus in the default-mode network?
por: Huiskamp, Marijn, et al.
Publicado: (2019)

Serum contactin-1 as a biomarker of long-term disease progression in natalizumab-treated multiple sclerosis
por: van Lierop, Zoë YGJ, et al.
Publicado: (2021)

Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias
por: Baiardi, Simone, et al.
Publicado: (2022)

Effect of Estimated Blood Volume and Body Mass Index on GFAP and NfL Levels in the Serum and CSF of Patients With Multiple Sclerosis
por: Yalachkov, Yavor, et al.
Publicado: (2022)

GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients
por: Gust, Juliane, et al.
Publicado: (2022)

Feasibility of cognitive rehabilitation in patients with advanced multiple sclerosis: A pilot study
por: Prouskas, Stefanos E, et al.
Publicado: (2021)

Functional training is a senseless strategy in MS cognitive rehabilitation: Strategy training is the only useful approach – NO
por: Hulst, Hanneke E, et al.
Publicado: (2017)

NEUROFILAMENT LIGHT CHAIN (NFL) AND GENERAL COGNITIVE ABILITY IN ADULTS APPROACHING MIDLIFE
por: Reynolds, Chandra, et al.
Publicado: (2022)

Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
por: Schindler, Patrick, et al.
Publicado: (2021)

The role of sleep on cognition and functional connectivity in patients with multiple sclerosis
por: van Geest, Quinten, et al.
Publicado: (2016)

Structure-function coupling as a correlate and potential biomarker of cognitive impairment in multiple sclerosis
por: Kulik, Shanna D., et al.
Publicado: (2022)

The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort
por: Loonstra, Floor C., et al.
Publicado: (2023)

The Use of Biologics in NFL Athletes: An Expert Consensus of NFL Team Physicians
por: Murray, Iain R., et al.
Publicado: (2023)

NFL strongly correlates with TNF-R1 in the plasma of AD patients, but not with cognitive decline
por: Delaby, Constance, et al.
Publicado: (2021)

Epidemiology of Navicular Injury at the NFL Combine and Their Impact on an Athlete’s Prospective NFL Career
por: Vopat, Bryan, et al.
Publicado: (2017)

Effect of Posterior Glenoid Labral Tears at the NFL Combine on Future NFL Performance
por: Murphy, Colin P., et al.
Publicado: (2018)

A population‐based meta‐analysis of circulating GFAP for cognition and dementia risk
por: Gonzales, Mitzi M., et al.
Publicado: (2022)

Plasma UCHL1, GFAP, Tau, and NfL Are Not Different in Young Healthy Persons With Mild COVID-19 Symptoms Early in the Pandemic: A Pilot Study
por: Rogatzki, Matthew J., et al.
Publicado: (2023)

Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis
por: Cruz-Gomez, Álvaro J., et al.
Publicado: (2021)

Serum NFL discriminates Parkinson disease from essential tremor and reflect motor and cognition severity
por: Huang, Yixian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ce4nn5kj39iva014sng4eg8ka6